Clinical Study
Preliminary Results of Hyperthermic Intraperitoneal Intraoperative Chemotherapy as an Adjuvant in Resectable Pancreatic Cancer
Table 1
Patients’ general characteristics.
| Male/Female | No. of patients | % | 9/12 | 42.9/57.1 |
| Tumor anatomic distribution | | | Head | 17 | 81 | Body | 1 | 4.8 | Tail | 3 | 14.3 |
| Performance status | | | 90–100% | 15 | 71.4 | 70–80% | 5 | 23.8 | 50–60% | 1 | 4.8 |
| Tumor infiltration | | | T1 | 1 | 4.8 | T2 | 3 | 14.3 | T3 | 17 | 81 |
| Nodal infiltration | | | N0 | 9 | 42.9 | N1 | 12 | 57.1 |
| TNM stage | | | I | 3 | 14.3 | II | 6 | 28.6 | III | 12 | 57.1 |
| Degree of differentiation | | | G1 | 4 | 19 | G2 | 9 | 42.9 | G3 | 8 | 38.1 |
| Residual tumor | | | R0 | 20 | 95.3 | R1 | 1 | 4.7 |
|
|